Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) is a common disorder affecting women of reproductive age and it is associated with increased cardiovascular risk. Obesity plays an important role in the pathogenesis of PCOS, and the majority of patients with PCOS are obese. Over the last 20 years, the prevalence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahal, Hassan, Atkin, Stephen L., Sathyapalan, Thozhukat
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010652/
https://www.ncbi.nlm.nih.gov/pubmed/21197149
http://dx.doi.org/10.1155/2011/402052
_version_ 1782194814337417216
author Kahal, Hassan
Atkin, Stephen L.
Sathyapalan, Thozhukat
author_facet Kahal, Hassan
Atkin, Stephen L.
Sathyapalan, Thozhukat
author_sort Kahal, Hassan
collection PubMed
description Polycystic ovary syndrome (PCOS) is a common disorder affecting women of reproductive age and it is associated with increased cardiovascular risk. Obesity plays an important role in the pathogenesis of PCOS, and the majority of patients with PCOS are obese. Over the last 20 years, the prevalence of obesity has dramatically increased, with probable associated increase in PCOS. Weight reduction plays an integral part in the management of women with PCOS. In this paper, current available weight reduction therapies in the management of PCOS are discussed.
format Text
id pubmed-3010652
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-30106522010-12-30 Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome Kahal, Hassan Atkin, Stephen L. Sathyapalan, Thozhukat J Obes Review Article Polycystic ovary syndrome (PCOS) is a common disorder affecting women of reproductive age and it is associated with increased cardiovascular risk. Obesity plays an important role in the pathogenesis of PCOS, and the majority of patients with PCOS are obese. Over the last 20 years, the prevalence of obesity has dramatically increased, with probable associated increase in PCOS. Weight reduction plays an integral part in the management of women with PCOS. In this paper, current available weight reduction therapies in the management of PCOS are discussed. Hindawi Publishing Corporation 2011 2010-12-15 /pmc/articles/PMC3010652/ /pubmed/21197149 http://dx.doi.org/10.1155/2011/402052 Text en Copyright © 2011 Hassan Kahal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Kahal, Hassan
Atkin, Stephen L.
Sathyapalan, Thozhukat
Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
title Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
title_full Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
title_fullStr Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
title_full_unstemmed Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
title_short Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
title_sort pharmacological treatment of obesity in patients with polycystic ovary syndrome
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010652/
https://www.ncbi.nlm.nih.gov/pubmed/21197149
http://dx.doi.org/10.1155/2011/402052
work_keys_str_mv AT kahalhassan pharmacologicaltreatmentofobesityinpatientswithpolycysticovarysyndrome
AT atkinstephenl pharmacologicaltreatmentofobesityinpatientswithpolycysticovarysyndrome
AT sathyapalanthozhukat pharmacologicaltreatmentofobesityinpatientswithpolycysticovarysyndrome

Ejemplares similares